GranuFlo and NaturaLyte are two products that are commonly used in dialysis treatments. The products have been associated with an increased risk for cardiopulmonary arrest and sudden cardiac death. The manufacturer of GranuFlo and NaturaLyte, Fresenium Medical Care (FMC), knew about the products dangers, but they failed to the alert medical professionals and patients.<\/p>\n
If GranuFlo or NaturaLyte were used during your dialysis treatment and you suffered an adverse side effect, you may have grounds for legal action. Contact a knowledgeable attorney today to explore your legal options.<\/p>\n
To receive a Free Case Review<\/strong>, fill out the contact form on the right.<\/p>\n <\/p>\n GranuFlo and NaturaLyte are dry acid products that are used in dialysis treatment to help remove waste from the blood. Unfortunately, many patients have reported serious side effects after using GranuFlo and NaturaLyte. Listed below are some adverse side effects associated with GranuFlo and NaturaLyte such as:<\/p>\n If you have experienced any of these health conditions after dialysis treatment, you may be eligible for legal and financial recourse.<\/p>\n To schedule a legal consultation, fill out the contact form on this page.<\/p>\n <\/p>\n The Food and Drug Administration (FDA) issued a Class 1 recall of GranuFlo and NaturaLyte in March 2012. A Class 1 recall<\/strong> is the most serious type of recall and it involves situations where there is a reasonable probability that that use of these products will cause serious adverse health consequences or death.<\/p>\n FMC conducted a study that evaluated the risk factors of dialysis patients who suffered cardiopulmonary arrest in FMC facilities compared to other dialysis patients in the same facilities between January 1 and December 31, 2010.<\/p>\n The results from the study found that 941 patients at over 600 FMC facilities had suffered cardiopulmonary arrests resulting in death.<\/p>\nGranuFlo and NaturaLyte Side Effects<\/h3>\n
\n
Fresenium Medical Care Knew About Heart Attack Risks<\/h3>\n